Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTOPICALGeneric

SYNERA

LIDOCAINE; TETRACAINE

Standard Dose
70MG;70MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview SYNERA is listed in Drugs@FDA under application 021623 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient LIDOCAINE; TETRACAINE Form and strength PATCH;TOPICAL - 70MG;70MG Sponsor GALEN SPECIALTY Submission history Latest submission status date: 2020-12-16 00:00:00.

Structured Monograph

Clinical summary

Approval overview SYNERA is listed in Drugs@FDA under application 021623 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient LIDOCAINE; TETRACAINE Form and strength PATCH;TOPICAL - 70MG;70MG Sponsor GALEN SPECIALTY Submission history Latest submission status date: 2020-12-16 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
SYNERA (LIDOCAINE; TETRACAINE) | Drug Monograph | MedicHelpline